US Patent Issued to Akamis Bio on July 28 for "Group B adenovirus-containing formulation" (British Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,150, issued on July 28, was assigned to Akamis Bio Inc. (Cambridge, Mass.).

"Group B adenovirus-containing formulation" was invented by Simon Alvis (Oxfordshire, Great Britain) and Magdalena Kieltyka (Oxfordshire, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to formulations suitable for the storage of group B adenoviruses, such as Enadenotucirev (EnAd), processes for making the formulations, and use of the formulations in methods of treatment."

The patent was filed on April 18, 2024, under Application No. 18/639,598.

*For further information, including images, charts and tables, please visit: http://p...